Session

Advances in cirrhosis

THE ASSOCIATION OF LIVER STEATOSIS ASSESSED BY THE CONTROLLED ATTENUATED PARAMETER AND SEVERITY OF LIVER DISEASE WITH THE PRESENCE OF CIRRHOTIC CARDIOMYOPATHY
THE ASSOCIATION OF LIVER STEATOSIS ASSESSED BY THE CONTROLLED ATTENUATED PARAMETER AND SEVERITY OF LIVER DISEASE WITH THE PRESENCE OF CIRRHOTIC CARDIOMYOPATHY

INFLUENCE OF NON NEOPLASTIC PORTAL VEIN THROMBOSIS ON SURVIVAL IN CIRRHOTIC PATIENTS WITH HEPATOCELLUAR CARICINOMA
INFLUENCE OF NON NEOPLASTIC PORTAL VEIN THROMBOSIS ON SURVIVAL IN CIRRHOTIC PATIENTS WITH HEPATOCELLUAR CARICINOMA

A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS

INCREASED SURVIVAL IN PATIENTS WITH HEPATIC ENCEPHALOPATHY TREATED WITH RIFAXIMIN-ALPHA IN COMBINATION WITH LACTULOSE: AN OBSERVATIONAL STUDY IN 4669 PATIENTS FROM UK CLINICAL PRACTICE
INCREASED SURVIVAL IN PATIENTS WITH HEPATIC ENCEPHALOPATHY TREATED WITH RIFAXIMIN-ALPHA IN COMBINATION WITH LACTULOSE: AN OBSERVATIONAL STUDY IN 4669 PATIENTS FROM UK CLINICAL PRACTICE

VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE
VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE

VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE
VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE

Advances in cirrhosis  et al.

INCREASED SURVIVAL IN PATIENTS WITH HEPATIC ENCEPHALOPATHY TREATED WITH RIFAXIMIN-ALPHA IN COMBINATION WITH LACTULOSE: AN OBSERVATIONAL STUDY IN 4669 PATIENTS FROM UK CLINICAL PRACTICE
INCREASED SURVIVAL IN PATIENTS WITH HEPATIC ENCEPHALOPATHY TREATED WITH RIFAXIMIN-ALPHA IN COMBINATION WITH LACTULOSE: AN OBSERVATIONAL STUDY IN 4669 PATIENTS FROM UK CLINICAL PRACTICE

Advances in cirrhosis  et al.

A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS

Advances in cirrhosis  et al.

INFLUENCE OF NON NEOPLASTIC PORTAL VEIN THROMBOSIS ON SURVIVAL IN CIRRHOTIC PATIENTS WITH HEPATOCELLUAR CARICINOMA
INFLUENCE OF NON NEOPLASTIC PORTAL VEIN THROMBOSIS ON SURVIVAL IN CIRRHOTIC PATIENTS WITH HEPATOCELLUAR CARICINOMA

Advances in cirrhosis  et al.

THE ASSOCIATION OF LIVER STEATOSIS ASSESSED BY THE CONTROLLED ATTENUATED PARAMETER AND SEVERITY OF LIVER DISEASE WITH THE PRESENCE OF CIRRHOTIC CARDIOMYOPATHY
THE ASSOCIATION OF LIVER STEATOSIS ASSESSED BY THE CONTROLLED ATTENUATED PARAMETER AND SEVERITY OF LIVER DISEASE WITH THE PRESENCE OF CIRRHOTIC CARDIOMYOPATHY

Advances in cirrhosis  et al.

Item 1 - 10 / 10
1